Firmani Lori
SEC CIK 1808248 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| DMRA | Damora Therapeutics, Inc. | Interim CFO | 1,066 | — | $4,858 | 6 | 2025-01-03 | 2026-01-02 |
Most active insiders at DMRA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Schambye Hans T. | CEO, Dir | — | $15.0K |
| 2 | Winslow Garrett | GC | — | $12.8K |
| 3 | Firmani Lori | CFO | — | $2,890 |
| 4 | Sattarzadeh Sherwin | COO | — | — |
| 5 | Bruno Julianne | Dir | — | — |
| 6 | Hewes L. Becker | Chief Medical Off | — | — |
| 7 | Fairmount Healthcare Fund II L.P. | 10% | — | — |
| 8 | Jarrett Jennifer | See Remarks, Dir | — | — |
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-01-06 | 2026-01-02 | DMRA | Damora Therapeutics, Inc. | Firmani Lori | CFO | M - OptEx | — | +374 | 1,066 | +54% | — |
| D | 2026-01-06 | 2026-01-02 | DMRA | Damora Therapeutics, Inc. | Firmani Lori | CFO | S - Sale+OE | $21.41 | -135 | 931 | -13% | -$2,890 |
| D | 2025-07-08 | 2025-07-03 | DMRA | Damora Therapeutics, Inc. | Firmani Lori | Interim CFO | M - OptEx | — | +374 | 839 | +80% | — |
| D | 2025-07-08 | 2025-07-03 | DMRA | Damora Therapeutics, Inc. | Firmani Lori | Interim CFO | S - Sale+OE | $3.39 | -147 | 692 | -18% | -$498.33 |
| D | 2025-01-07 | 2025-01-03 | DMRA | Damora Therapeutics, Inc. | Firmani Lori | Interim CFO | M - OptEx | — | +726 | 726 | New | — |
| D | 2025-01-07 | 2025-01-03 | DMRA | Damora Therapeutics, Inc. | Firmani Lori | Interim CFO | S - Sale+OE | $5.63 | -261 | 465 | -36% | -$1,469 |
Purchase Sale Sale after option exercise All abbreviations